4.6 Review

Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials

Related references

Note: Only part of the references are listed.
Article Nanoscience & Nanotechnology

Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy

Yuang Chen et al.

Summary: The activation of scramblases, a mechanism that regulates the exposure of phosphatidylserine on cell surfaces, plays an important role in tumor immunosuppression. In this study, the researchers found that chemotherapeutic agents induce overexpression of a specific scramblase, Xkr8, in cancer cells. They developed a nanocarrier that can deliver Xkr8 short interfering RNA and a cancer prodrug to tumors, leading to significant inhibition of tumor growth and increased antitumor immune response in animal models. Targeting Xkr8 in combination with chemotherapy may be a promising strategy for treating different types of cancers.

NATURE NANOTECHNOLOGY (2023)

Article Pharmacology & Pharmacy

Clinical Impact of Antipolyethylene Glycol (PEG) Antibody in Hematological Patients Administered PEGylated-Granulocyte Colony-Stimulating Factor

Naoto Okada et al.

Summary: Polyethylene glycol (PEG) is a polymer attached to proteins to improve their half-life and efficacy, but PEG-G-CSF has been found to be immunogenic and potentially affect drug efficacy and safety. In this study, the relationship between anti-PEG antibody titers and the clinical impact of PEG-G-CSF was analyzed in 19 hematological patients. The results showed that high titers of anti-PEG antibodies may be associated with the development of adverse events after PEG-G-CSF administration, including noninfectious fever.

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2023)

Article Chemistry, Multidisciplinary

A Dual-Biomineralized Yeast Micro-/Nanorobot with Self-Driving Penetration for Gastritis Therapy and Motility Recovery

Lishan Zhang et al.

Summary: A self-driving yeast micro/nanorobot (Cur@ CaY-robot) is designed via dual biomineralization and acid catalysis, which demonstrates efficient motion in gastric acid and can penetrate the thick gastric mucus for improved drug accumulation in the stomach wall tissue. Additionally, the released Ca2+ cations from the robot synergistically repair the gastric motility of gastritis mice. The biocompatible and biodegradable nature of these yeast micro/nanorobots, along with their good drug loading capacity, make them promising for active drug delivery and precise therapy.

ACS NANO (2023)

Article Chemistry, Multidisciplinary

Overcoming drug resistance with a docetaxel and disulfiram loaded pH-sensitive nanoparticle

K. Laxmi Swetha et al.

Summary: Previous studies have shown that breast cancer cells employ various strategies to resist anticancer drugs, such as docetaxel, through drug-resistance mechanisms like overexpression of P-glycoprotein and cancer stem cells. By inhibiting both P-glycoprotein and cancer stem cells, the combination of docetaxel and disulfiram shows potential in sensitizing drug-resistant breast cancer cells. This study developed a pH-responsive nanoparticle system for the co-delivery of docetaxel and disulfiram, which demonstrated improved drug release, penetration, and cytotoxic efficacy against drug-resistant breast cancer cells in vitro, as well as enhanced tumor drug delivery and anti-tumor efficacy in vivo.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Chemistry, Multidisciplinary

Co-delivery of microRNA-150 and quercetin by lipid nanoparticles (LNPs) for the targeted treatment of age-related macular degeneration (AMD)

Wei Li et al.

Summary: Age-related macular degeneration (AMD) is a disease that causes severe vision loss in middle-aged and elderly patients due to choroidal neovascularization (CNV). Current treatments for CNV are ineffective and can have adverse effects. This study developed solid lipid nanoparticles modified with an Asp-Gly-Arg peptide to target endothelial cells during abnormal angiogenesis. These nanoparticles successfully co-delivered microRNA-150 (mR150) and the antiangiogenic drug quercetin, inhibiting CNV without retinal toxicity in a mouse model.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Pharmacology & Pharmacy

Cisplatin-loaded thermoresponsive liposomes for enhanced anticancer efficacy

Hassan Shah et al.

Summary: Thermoresponsive liposomes loaded with cisplatin (CDDP@TSLs) were developed and characterized for enhanced anticancer efficacy. The results showed that CDDP@TSLs exhibited greater cytotoxicity against various cancer cells at 39℃ and higher cellular uptake at tumor sites. In a mouse model of lung carcinoma, CDDP@TSL treatment demonstrated good therapeutic effect. The developed CDDP@TSLs may provide an enhanced anticancer efficacy and minimize systemic toxicities.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2023)

Review Pharmacology & Pharmacy

Stealth and pseudo-stealth nanocarriers

Panyue Wen et al.

Summary: The stealth effect is crucial for enhancing the capabilities of nanomaterials in drug delivery applications. Through analyzing the efficiency and factors involved, we propose an integrated perspective on engineering stealth nanomaterials. The analysis reveals a common pharmacokinetics behavior, known as the pseudo-stealth effect, which leads to a rapid drop in blood concentration despite a relatively long b-phase. We suggest that a holistic approach, considering surface structure and geometry, is essential for improving the stealth effect.

ADVANCED DRUG DELIVERY REVIEWS (2023)

Article Chemistry, Multidisciplinary

Targeted Nanoparticle for Co-delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis

Worapol Ngamcherdtrakul et al.

Summary: The first-line treatment of advanced and metastatic human epidermal growth factor receptor type 2 (HER2+) breast cancer requires a combination of two antibodies and a taxane. However, this treatment is expensive, time-consuming, and has limited efficacy. To overcome these limitations, a single therapeutic based on nanoparticles has been developed, which can co-deliver drugs and siRNA to specifically target HER2-positive breast cancer cells.

SMALL (2022)

Review Medicine, Research & Experimental

Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy

Bin Ji et al.

Summary: Cancer immunotherapy has shown great progress in advanced-stage malignancies, but low response rates and immunosuppressive tumor microenvironments limit its effectiveness. Photodynamic therapy (PDT) can induce immunogenic cell death and enhance immune responses. Recent nanomedicine-based strategies have improved the efficiency of PDT and immunotherapy, and synergistic nanotherapeutics have been used to amplify immune responses. Challenges and future expectations in PDT-driven cancer immunotherapy are discussed.

THERANOSTICS (2022)

Article Pharmacology & Pharmacy

Discovery in polyethylene glycol immunogenicity: The characteristic of intergenerational inheritance of anti-polyethylene glycol IgG

Xin Gao et al.

Summary: Several studies have reported the widespread existence of anti-polyethylene glycol (PEG) antibodies (APAs) in healthy individuals. This study utilized Wistar rats as a model organism and found that the presence of antibodies in parental rats can affect antibody production in their offspring, showing intergenerational inheritance of anti-PEG immunoglobulin G (IgG). Additionally, the offspring's IgG can bind to PEG and accelerate its clearance from the blood.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2022)

Review Chemistry, Multidisciplinary

Targeted nanomedicine in cisplatin-based cancer therapeutics

Yu Han et al.

Summary: Cisplatin is a successful chemotherapy drug, but its resistance and toxicity limit its clinical application. Targeted nanomedicine offers hope for maximizing efficacy and minimizing toxicity. This article reviews the recent progress and challenges in managing cisplatin resistance and toxicity and highlights future directions for development.

JOURNAL OF CONTROLLED RELEASE (2022)

Review Chemistry, Multidisciplinary

The Janus of Protein Corona on nanoparticles for tumor targeting, immunotherapy and diagnosis

Xiaobo Wang et al.

Summary: Nanoparticle-based therapeutics hold promise for tumor detection and treatment. However, the adsorption of biomolecules on nanoparticles in biological medium can lead to unpredictable in vivo behaviors. The interaction caused by protein corona affects blood circulation, cellular uptake, and interactions with immune cells. Protein corona can also serve as a novel biomarker for tumor diagnosis.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Engineering, Biomedical

Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles

Martijn J. W. Evers et al.

Summary: EV-liposome hybrid nanoparticles have been investigated as a potential siRNA delivery system, demonstrating their ability to encapsulate siRNA, contain EV-surface markers, and functionally deliver siRNA to different cell types. These hybrids combine the benefits of both synthetic and biological drug delivery systems, showing altered functional behavior compared to liposomes and varying efficacy among recipient cell types.

ADVANCED HEALTHCARE MATERIALS (2022)

Review Biochemistry & Molecular Biology

Macrophage-Derived Extracellular Vesicles: A Promising Tool for Personalized Cancer Therapy

Antonella Barone et al.

Summary: The incidence of cancer is increasing significantly and the lack of efficacy in cancer therapies can be attributed to various factors such as delayed diagnosis, tumor regrowth, and multidrug resistance. Macrophages play a crucial role in tumor suppression or progression, and macrophage-derived extracellular vesicles (EVs) are important mediators in the tumor microenvironment. Their ability to facilitate cell-cell and organ-cell communication by delivering nucleic acids and proteins makes them potential targets for personalized anticancer nanomedicine.

BIOMEDICINES (2022)

Review Pharmacology & Pharmacy

The effects of protein corona on in vivo fate of nanocarriers

Qingqing Xiao et al.

Summary: This review provides an overview of the formation of protein corona (PC) on nanocarriers in vivo and its effects on the physicochemical properties and biological behaviors of nanocarriers. Design strategies for engineering PC to control the surface properties of nanocarriers are proposed.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Review Pharmacology & Pharmacy

Organ-specific endothelial cell heterogenicity and its impact on regenerative medicine and biomedical engineering applications

Max Urbanczyk et al.

Summary: Endothelial cells play a key role in the vascular system, but their heterogeneity is often overlooked in vitro models. This review introduces different types of endothelial cells and their characteristics, and discusses the utilization of in vitro models for studying the role of endothelium in health and disease.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Article Engineering, Biomedical

Nanocarriers escaping from hyperacidified endo/lysosomes in cancer cells allow tumor-targeted intracellular delivery of antibodies to therapeutically inhibit c-MYC

Pengwen Chen et al.

Summary: Intracellular protein delivery is an effective approach for developing innovative therapeutics. Nanocarriers have the potential to deliver proteins inside cells by promoting cellular uptake and overcoming degradation. Controlling the ability of nanocarriers to escape from the endo/lysosomal compartments can enhance delivery precision.

BIOMATERIALS (2022)

Article Biochemistry & Molecular Biology

Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects

Xiaojun Wang et al.

Summary: The researchers successfully developed M1-like macrophage-derived extracellular vesicles (M1EVs) for the treatment of glioblastoma multiforme (GBM). These M1EVs achieved synergistic immunomodulation, chemiexcited photodynamic therapy (CDT), and hypoxia-activated chemotherapy in GBM, leading to a potent therapeutic effect. The results demonstrated the excellent efficacy of CCA-M1EVs against GBM in cell-derived and patient-derived xenograft models.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Nanoscience & Nanotechnology

Thermosensitive magnetic nanoparticles exposed to alternating magnetic field and heat-mediated chemotherapy for an effective dual therapy in rat glioma model

Reza Afzalipour et al.

Summary: The study showed that the combination therapy of AFM hyperthermia with thermosensitive TMZ/MNPs-FA could significantly suppress tumor growth, increase survival rate, and promote apoptosis.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2021)

Article Chemistry, Multidisciplinary

Enzymatically Transformable Polymersome-Based Nanotherapeutics to Eliminate Minimal Relapsable Cancer

Junjie Li et al.

Summary: This study introduces a nanotherapeutic approach targeting postsurgical cancer microresiduals by utilizing matrix metalloproteinase activation in tissues to improve treatment effectiveness, which can effectively reduce the risk of cancer metastasis and local recurrence.

ADVANCED MATERIALS (2021)

Article Chemistry, Multidisciplinary

Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation

Junjie Li et al.

Summary: The text emphasizes the evolution of nanomedicine from biologically inert entities to smarter systems aimed at advancing in vivo functionality. It highlights the importance of focusing on nano-bio interactions and desirable functionality in tissue, cellular, and molecular levels, as well as providing definitive evidence for proof-of-mechanism.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Article Engineering, Biomedical

Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models

Maofan Zhang et al.

Summary: Chemoradiotherapy with cisplatin and etoposide has shown to be effective in treating both small and non-small cell lung cancers, but with high toxicity. Utilizing nanotherapeutics in nanoparticle formulation may offer a more effective and less toxic treatment option, especially in combination chemotherapy for lung cancer.

ACTA BIOMATERIALIA (2021)

Article Chemistry, Multidisciplinary

Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice

Sherif E. Emam et al.

Summary: The study demonstrates that injection of PEGylated exosomes induces the production of anti-PEG IgM, leading to decreased blood concentrations of a second dose of PEGylated exosomes and suppressed tumor accumulation. Additionally, the dose of PEGylated exosomes can affect the production of anti-PEG IgM.

JOURNAL OF CONTROLLED RELEASE (2021)

Review Nanoscience & Nanotechnology

Nanoparticles for Cancer Therapy: Current Progress and Challenges

Shreelaxmi Gavas et al.

Summary: Nanotechnology has revolutionized cancer diagnosis and treatment by overcoming limitations of traditional therapies and multidrug resistance. Nanoparticles, with their unique advantages, offer new perspectives for cancer treatment. However, challenges still exist in research and clinical translation of nanotherapeutics.

NANOSCALE RESEARCH LETTERS (2021)

Review Medicine, Research & Experimental

Recent progress in nanomedicine for enhanced cancer chemotherapy

Guoqing Wei et al.

Summary: Nanomedicine has shown significant progress in improving cancer chemotherapy, including drug enrichment and tissue penetration, subcellular organelle-targeted chemotherapy, and reversal of multidrug resistance. The advantages of combination therapy in cancer treatment are emphasized.

THERANOSTICS (2021)

Article Pharmacology & Pharmacy

Nanoliposomes as Multidrug Carrier of Gemcitabine/Paclitaxel for the Effective Treatment of Metastatic Breast Cancer Disease: A Comparison with Gemzar and Taxol

Christian Celia et al.

Summary: Nanoliposomes co-delivering gemcitabine hydrochloride and paclitaxel significantly decrease cell viability, reduce tumor growth and improve survival times in metastatic breast cancer compared to combination treatment with the free drugs. Pharmacokinetic analysis shows that nanoliposomes increase the half-life of gemcitabine hydrochloride and paclitaxel, suggesting an effective treatment strategy for metastatic breast cancer.

ADVANCED THERAPEUTICS (2021)

Review Chemistry, Multidisciplinary

Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery

Hannah J. Vaughan et al.

ADVANCED MATERIALS (2020)

Article Pharmacology & Pharmacy

Novel radiopharmaceutical (Technetium-99m)-(DOTA-NHS-ester)-Methionine as a SPECT-CT tumor imaging agent

Paria Mojarrad et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Review Pharmacology & Pharmacy

Formulation Strategies for Folate-Targeted Liposomes and Their Biomedical Applications

Parveen Kumar et al.

PHARMACEUTICS (2019)

Article Chemistry, Multidisciplinary

Folate-targeted pH-sensitive bortezomib conjugates for cancer treatment

Yin Liu et al.

CHEMICAL COMMUNICATIONS (2019)

Article Oncology

Cancer Statistics, 2018

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Review Nanoscience & Nanotechnology

Recent advances in functional nanostructures as cancer photothermal therapy

Essraa A. Hussein et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)

Review Chemistry, Multidisciplinary

Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities

Lisa Belfiore et al.

JOURNAL OF CONTROLLED RELEASE (2018)

Review Nanoscience & Nanotechnology

Nanoparticle-mediated cryosurgery for tumor therapy

Yi Hou et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)

Article Multidisciplinary Sciences

NIR-II nanoprobes in-vivo assembly to improve image-guided surgery for metastatic ovarian cancer

Peiyuan Wang et al.

NATURE COMMUNICATIONS (2018)

Article Engineering, Biomedical

Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA

Mohammad Ariful Islam et al.

NATURE BIOMEDICAL ENGINEERING (2018)

Review Nanoscience & Nanotechnology

Bioresponsive materials

Yue Lu et al.

NATURE REVIEWS MATERIALS (2017)

Article Engineering, Biomedical

A transistor-like pH nanoprobe for tumour detection and image-guided surgery

Tian Zhao et al.

NATURE BIOMEDICAL ENGINEERING (2017)

Article Chemistry, Multidisciplinary

Overcoming key biological barriers to cancer drug delivery and efficacy

Susy M. Kim et al.

JOURNAL OF CONTROLLED RELEASE (2017)

Article Chemistry, Multidisciplinary

Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity

Yu Mima et al.

JOURNAL OF CONTROLLED RELEASE (2017)

Article Chemistry, Multidisciplinary

Revisiting the use of sPLA2-sensitive liposomes in cancer therapy

Houman Pourhassan et al.

JOURNAL OF CONTROLLED RELEASE (2017)

Article Pharmacology & Pharmacy

Tumor-targeted nanomedicines for cancer theranostics

Alexandra G. Arranja et al.

PHARMACOLOGICAL RESEARCH (2017)

Review Chemistry, Multidisciplinary

Nanotechnology for Multimodal Synergistic Cancer Therapy

Wenpei Fan et al.

CHEMICAL REVIEWS (2017)

Article Chemistry, Multidisciplinary

MXene Ti3C2: An Effective 2D Light-to-Heat Conversion Material

Renyuan Li et al.

ACS NANO (2017)

Article Chemistry, Multidisciplinary

Biodegradable Inorganic Nanovector: Passive versus Active Tumor Targeting in siRNA Transportation

Dae-Hwan Park et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)

Article Chemistry, Multidisciplinary

Niosomes as Drug Nanovectors: Multiscale pH-Dependent Structural Response

Carlotta Marianecci et al.

LANGMUIR (2016)

Article Multidisciplinary Sciences

A DNA dual lock-and-key strategy for cell-subtype-specific siRNA delivery

Kewei Ren et al.

NATURE COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

Core-shell nanocarriers with high paclitaxel loading for passive and active targeting

Zhu Jin et al.

SCIENTIFIC REPORTS (2016)

Article Chemistry, Multidisciplinary

X-ray Radiation-Controlled NO-Release for On-Demand Depth-Independent Hypoxic Radiosensitization

Wenpei Fan et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)

Review Pharmacology & Pharmacy

Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy

Edgar Perez-Herrero et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)

Article Oncology

Cardiovascular Disease in Survivors of Adolescent and Young Adult Cancer: A Danish Cohort Study, 1943-2009

Kathrine Rugbjerg et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)

Review Nanoscience & Nanotechnology

A sight on the current nanoparticle-based gene delivery vectors

Solmaz Maleki Dizaj et al.

NANOSCALE RESEARCH LETTERS (2014)

Review Chemistry, Multidisciplinary

Nano-Sized CT Contrast Agents

Nohyun Lee et al.

ADVANCED MATERIALS (2013)

Article Medicine, Research & Experimental

The role and mechanisms of nanoparticles to enhance radiosensitivity in hepatocellular cell

Qin Zheng et al.

BIOMEDICINE & PHARMACOTHERAPY (2013)

Article Oncology

Nanomedicines as Cancer Therapeutics: Current Status

Sohail Akhter et al.

CURRENT CANCER DRUG TARGETS (2013)

Review Chemistry, Physical

Stimuli-responsive nanocarriers for drug delivery

Simona Mura et al.

NATURE MATERIALS (2013)

Review Engineering, Biomedical

The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems

Alexandre Albanese et al.

ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 14 (2012)

Article Pharmacology & Pharmacy

Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model

Donatella Paolino et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)

Review Pharmacology & Pharmacy

Recent advances in brain tumor-targeted nano-drug delivery systems

Yu Liu et al.

EXPERT OPINION ON DRUG DELIVERY (2012)

Review Chemistry, Multidisciplinary

Nanotechnology applied to overcome tumor drug resistance

Zibin Gao et al.

JOURNAL OF CONTROLLED RELEASE (2012)

Review Chemistry, Multidisciplinary

The journey of a drug-carrier in the body: An anatomo-physiological perspective

Nicolas Bertrand et al.

JOURNAL OF CONTROLLED RELEASE (2012)

Article Chemistry, Multidisciplinary

Chemical Molecule-Induced Light-Activated System for Anticancer and Antifungal Activities

Huanxiang Yuan et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)

Article Medicine, Research & Experimental

Copolymer Micelles and Nanospheres with Different In Vitro Stability Demonstrate Similar Paclitaxel Pharmacokinetics

Kevin Letchford et al.

MOLECULAR PHARMACEUTICS (2012)

Review Biochemistry & Molecular Biology

Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics

Jianqiu Wang et al.

CURRENT DRUG METABOLISM (2010)

Article Pharmacology & Pharmacy

The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro

Wu

International Journal of Nanomedicine (2010)

Article Orthopedics

Persistent Mobility Disability After Neurotoxic Chemotherapy

Elizabeth S. Hile et al.

PHYSICAL THERAPY (2010)

Review Chemistry, Multidisciplinary

Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release

Chris Oerlemans et al.

PHARMACEUTICAL RESEARCH (2010)

Article Hematology

Heterogeneity of the Tumor Vasculature

Janice A. Nagy et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)

Review Oncology

Therapeutic nanoparticles for drug delivery in cancer

Kwangjae Cho et al.

CLINICAL CANCER RESEARCH (2008)

Article Medicine, Research & Experimental

Factors affecting the clearance and biodistribution of polymeric nanoparticles

Frank Alexis et al.

MOLECULAR PHARMACEUTICS (2008)

Review Oncology

New frontiers in nanotechnology for cancer treatment

Frank Alexis et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)

Article Chemistry, Multidisciplinary

In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug

Refika I. Pakunlu et al.

JOURNAL OF CONTROLLED RELEASE (2006)

Article Pharmacology & Pharmacy

Nanoparticle-induced platelet aggregation and vascular thrombosis

A Radomski et al.

BRITISH JOURNAL OF PHARMACOLOGY (2005)

Review Oncology

The role of ABC transporters in clinical practice

GD Leonard et al.

ONCOLOGIST (2003)

Review Oncology

Advancing the field of drug delivery: Taking aim at cancer

MA Moses et al.

CANCER CELL (2003)

Article Chemistry, Multidisciplinary

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

H Maeda et al.

JOURNAL OF CONTROLLED RELEASE (2000)